Clinical Trial

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

Name: Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo — clinical trial record (NCT07172347)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-08.

Status change: Not Yet Recruiting → Recruiting 2025-12-29

Trial Details

NCT Number	NCT07172347
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Non-segmental Vitiligo
Enrollment	120 participants
Start Date	2025-10-31
Primary Completion	2027-08-30 (estimated)
Study Completion	2027-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-02